Report the first Phase 2 interim analysis of the mRNA-1647 CMV vaccine study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 26 Feb 2020
- Due
- 30 Sep 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“first Phase 2 interim analysis expected in the third quarter of 2020”
What we found
Evidence strength A What the grades mean
A later 10-Q states positive Phase 2 interim data for mRNA-1647 were announced in September 2020, within the third-quarter 2020 window. The exact day is not given.
-
A Moderna 10-Q filed 2020-10-30
“Positive interim data from the Phase 2 study assessing the safety, reactogenicity, and immunogenicity of different dose levels of mRNA-1647 were announced in September 2020.” ✓ confirmed on the page
Market reaction: the shares moved -4.9% against the S&P 500 over the three sessions around the disclosure (29 Oct 2020 to 3 Nov 2020). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- First Phase 2 interim analysis of mRNA-1647 CMV vaccine study
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Moderna? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-MRNA-005744 · Corrections policy